256
Views
10
CrossRef citations to date
0
Altmetric
Editorial

The pharmacotherapy of overactive bladder

, MD PhD
Pages 1003-1005 | Published online: 04 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Niladri Sengupta & Timothy Hillard. (2013) Urogynecological risk assessment in postmenopausal women. Expert Review of Obstetrics & Gynecology 8:6, pages 625-637.
Read now

Articles from other publishers (9)

J. Kutzenberger, A. Angermund, B. Domurath, S. Möhr, J. Pretzer, I. Soljanik & R. Kirschner-Hermanns. (2022) Kurzfassung der S2k-Leitlinie medikamentöse Therapie der neurogenen Dysfunktion des unteren Harntraktes (NLUTD)Short version of the S2k guideline on drug therapy of neurogenic lower urinary tract dysfunction (NLUTD). Die Urologie 62:1, pages 41-52.
Crossref
Kayoko Ito, Makoto Inoue, Hisae Nishii & Tetsuro Matsumoto. (2020) Prevalence of xerostomia with or without overactive bladder symptoms. LUTS: Lower Urinary Tract Symptoms 13:2, pages 224-229.
Crossref
Ulrich Mehnert, Emmanuel Chartier-Kastler, Stefan de Wachter, Philip E.V.A. van Kerrebroeck & Gommert A. van Koeveringe. (2018) The Management of Urine Storage Dysfunction in the Neurological Patient. SN Comprehensive Clinical Medicine 1:3, pages 160-182.
Crossref
Sheng-Mou Hsiao & Ho-Hsiung Lin. (2018) Medical treatment of female overactive bladder syndrome and treatment-related effects. Journal of the Formosan Medical Association 117:10, pages 871-878.
Crossref
Alan C. Kinlaw, Michele Jonsson Funk, Mitchell M. Conover, Virginia Pate, Alayne D. Markland & Jennifer M. Wu. (2018) Impact of New Medications and $4 Generic Programs on Overactive Bladder Treatment Among Older Adults in the United States, 2000–2015. Medical Care 56:2, pages 162-170.
Crossref
Alan C. Kinlaw, Michele Jonsson Funk, Michael J. Steiner, Mitchell M. Conover, Virginia Pate & Jennifer M. Wu. (2016) Trends in Pharmacotherapy for Bladder Dysfunction Among Children in the United States, 2000 to 2013. Clinical Pediatrics 56:1, pages 55-64.
Crossref
Nadir I Osman & Christopher R Chapple. (2013) The management of overactive bladder syndrome: a review of the European Association of Urology Guidelines. Clinical Practice 10:5, pages 593-606.
Crossref
Kirill Kosilov, Sergey Loparev, Marina Ivanovskaya & Lily Kosilova. (2013) Management of Overactive Bladder (OAB) in Elderly Men and Women with Combined, High-Dosed Antimuscarinics without Increased Side Effects. UroToday International Journal 06:04.
Crossref
Masayuki Takeda. (2012) Re: Kanai A, et al. mechanisms of action of botulinum neurotoxins, β3‐adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI‐RS 2011. Neurourol urodyn 2012;31:300–308. Neurourology and Urodynamics 31:5, pages 707-707.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.